fructose 2,6-diphosphate has been researched along with Benign Neoplasms, Brain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ding, Z; Du, L; Guo, W; Jiang, T; Lee, JH; Li, J; Li, XJ; Liu, R; Lorenzi, PL; Lu, Z; Mills, GB; Qian, X; Tan, L; Wang, Y; Xia, Y; Xu, D; Zhang, C; Zheng, Y | 1 |
1 other study(ies) available for fructose 2,6-diphosphate and Benign Neoplasms, Brain
| Article | Year |
|---|---|
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
Topics: Acetylation; Adaptor Proteins, Signal Transducing; Animals; Brain Neoplasms; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Enzyme Activation; ErbB Receptors; Feedback, Physiological; Fructosediphosphates; Glioblastoma; Glucose Transporter Type 1; Glycolysis; Humans; Lysine Acetyltransferase 5; Male; Mice, Inbred BALB C; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphofructokinase-1, Type C; Phosphofructokinase-2; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Signal Transduction; src Homology Domains | 2018 |